Let’s face it, one of the most proficient ways to check your health is with a drop of blood. A medical practitioner will simply prick your finger, squeeze out a drop of blood before loading it into a machine almost the size of a small microwave oven. Through the blood test, your doctor can easily figure out the next step of action to take.
No wonder blood tests will continue to play a big role in managing our health while at the same preventing common diseases. To ensure the results are as accurate as possible, medical practitioners are now leveraging new blood testing technology that detect fragments of DNA circulating in our bloodstream. Either way, there is more than could be learned from a drop of blood provided we are counting on the right tests.
The good news is that numerous companies worldwide are already trying to develop sophisticated, but inexpensive blood tests. This is quite fascinating as it goes a long way in making sure medical practitioners discover more from a simple drop of blood. But will these tests ever become something that patients can routinely take at a doctor’s office?
Well, this is definitely going to pass one day if the new blood testing technology driving personalized care in lung cancer treatment is anything to go by. Nowadays, liquid biopsy is highly relied upon in tracking EGFR mutation in lung cancer case. Better, it is also applicable for the identification of KRAS and NRAS mutations in colon cancer patients.
Despite the fact that there is a huge acceptance among oncologists and primary physicians when it comes to liquid biopsy, there is more that needs to be done. Fortunately, some governments are already offering a helping hand in this regard by subsidizing the cost of targeted therapies. This action is aimed at making sure patients can access new blood tests without taking tolls on their finances.
The Bottom Line
New blood testing technology is slowly becoming the way to go when looking forward to offering the perfect treatment to patients. To find out more regarding the promise of liquid biopsy for lung cancer, consider checking out Roche Diagram publication. This regional healthcare magazine published by Roche Diagnostics is aimed at driving discussion around the value of diagnostics. Check out Roche Diagram online platform today and keep pace with everything that is transpiring.
